Trifluridine how supplied: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
 
Line 7: Line 7:


Store under refrigeration 2° to 8°C (36° to 46°F).<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211s000_sumr.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211s000_sumr.pdf | publisher = |date = | accessdate = }}</ref>
Store under refrigeration 2° to 8°C (36° to 46°F).<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211s000_sumr.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211s000_sumr.pdf | publisher = |date = | accessdate = }}</ref>
==References==
==References==
{{Reflist}}
{{Reflist}}

Latest revision as of 22:27, 2 January 2014

Trifluridine
VIROPTIC® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

How Supplied

VIROPTIC Ophthalmic Solution, 1% is supplied as a sterile ophthalmic solution in a plastic Drop Dose® dispenser bottle of 7.5 mL (NDC 61570-037-75).

Store under refrigeration 2° to 8°C (36° to 46°F).[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211s000_sumr.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.